TruSight Oncology ctDNA v2

About Illumina

Illumina stands as the dominant player in the DNA sequencing market, powering genomic discoveries across research institutions, clinical laboratories, and pharmaceutical companies worldwide. With a comprehensive portfolio spanning benchtop to production-scale sequencers like the NovaSeq X Series and NextSeq systems, the company enables applications from whole genome sequencing to single-cell analysis. Illumina's technology platform drives advances in precision medicine, oncology research, reproductive health, and agricultural genomics, while their flexible financing solutions and robust support ecosystem make genomic technologies accessible to laboratories of all sizes.

Therapeutic Areas